Rates do not apply to holidays, Easter, long weekends, national holidays, Christmas or New Year
GLP-1 Receptor Activation: Suppresses appetite through hypothalamic pathways Slows gastric emptying Enhances insulin secretion GIP Receptor Activation: Amplifies GLP-1 satiety effects Improves insulin sensitivity May directly affect fat cell metabolism Glucagon Receptor Activation: Increases energy expenditure (metabolic rate) Promotes fat breakdown (lipolysis) May prevent metabolic adaptation The Advantage: Single molecule means simpler manufacturing, potentially easier regulatory approval, and all three pathways activated with every dose
They found that in addition to slowing the progression of degeneration in the treatment group compared to controls, the peptide also improved levels of the protein aggrecan
Lingvay I, Sumithran P, le Roux CW, Cohen RV
This isn't theoretical speculation or biohacker experimentation We have extensive clinical data from the REDEFINE trials showing exactly how to dose both peptides together for maximum efficacy with manageable side effects